Showing results (321-330 of 334) with videos related to
Sort By:
Pageof 34
The International Journal on Drug Policy|November 4, 2021
Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependenceMichael Farrell, Jeyran Shahbazi, Marianne Byrne, et al.Archives of Sexual Behavior|January 18, 2022
Increase in Depression and Anxiety Among Australian Gay and Bisexual Men During COVID-19 Restrictions: Findings from a Prospective Online Cohort StudyBenjamin R Bavinton, Curtis Chan, Mohamed A Hammoud, et al.The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.Journal of Pain and Symptom Management|February 23, 2025
Design Considerations for Medicinal Cannabis Clinical Trials in People Receiving Palliative CareValentina Razmovski-Naumovski, Jennifer H Martin, Richard Chye, et al.Addiction (Abingdon, England)|December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trialNadine Ezard, Brendan Clifford, Krista J Siefried, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2020
HIV Preexposure Prophylaxis Cascades to Assess Implementation in Australia: Results From Repeated, National Behavioral Surveillance of Gay and Bisexual Men, 2014-2018Martin Holt, Evelyn Lee, Toby Lea, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 2020
Physical Distancing Due to COVID-19 Disrupts Sexual Behaviors Among Gay and Bisexual Men in Australia: Implications for Trends in HIV and Other Sexually Transmissible InfectionsMohamed A Hammoud, Lisa Maher, Martin Holt, et al.Drug and Alcohol Review|November 28, 2019
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectivesNicholas Lintzeris, Lauren A Monds, Maria Bravo, et al.BMJ Open|September 14, 2018
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)Antony J Mersiades, Annette Tognela, Paul S Haber, et al.BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.Pageof 34